Entitlement offer weighted average with last traded price of 27.5 cents work out to 26.5cent. So, with entitlement offer price discount not so bad. Main question is the $3million institution offer, will they just quick flip it or is it long turn. If long term, selling pressure should not be very large. ROW sales definitely disappointing, is there negative implications?
In the presentation page 30, what do HOPD and ASC means?
Also who owns " Molteno3 Glaucoma Drainagedevice " ? What is main message of page30?
Appreciate anyone can explain.
Entitlement offer weighted average with last traded price of...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $43.52M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $16.50K | 87.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68058 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 439 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |